These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36447162)

  • 1. Cardiovascular risk management: the success of target level achievement in high- and very high-risk patients in Hungary.
    Jancsó Z; Csenteri O; Szőllősi GJ; Vajer P; Andréka P
    BMC Prim Care; 2022 Nov; 23(1):305. PubMed ID: 36447162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Care management of patients with high cardiovascular risk in Hungary an international and Hungarian longitudinal comparison of target level achievement.
    Jancsó Z; Rurik I; Kolozsvári L; Mester L; Nánási A; Oláh C; Ungvári T; TCs KV; Kalabay L; Torzsa P
    BMC Fam Pract; 2020 May; 21(1):83. PubMed ID: 32384878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary care of patients with high cardiovascular risk : Blood pressure, lipid and diabetic target levels and their achievement in Hungary.
    Szigethy E; Jancsó Z; Móczár C; Ilyés I; Kovács E; Róbert Kolozsvári L; Rurik I
    Wien Klin Wochenschr; 2013 Jul; 125(13-14):371-80. PubMed ID: 23824265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary.
    Mark L; Vallejo-Vaz AJ; Reiber I; Paragh G; Kondapally Seshasai SR; Ray KK
    Atherosclerosis; 2015 Jul; 241(1):62-8. PubMed ID: 25966441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in the achievement of HbA
    Bakke Å; Dalen I; Thue G; Cooper J; Skeie S; Berg TJ; Jenum AK; Claudi T; Fjeld Løvaas K; Sandberg S
    Diabet Med; 2020 Sep; 37(9):1471-1481. PubMed ID: 31651045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of cardiometabolic risk reduction in patients with type 1 diabetes mellitus].
    Nádas J; Putz Z; Fövényi J; Gaál Z; Gyimesi A; Hídvégi T; Hosszúfalusi N; Neuwirth G; Oroszlán T; Pánczél P; Vándorfi G; Winkler G; Wittmann I; Jermendy G
    Orv Hetil; 2008 Jul; 149(27):1263-9. PubMed ID: 18579465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring quality of care and social inequalities related to type 2 diabetes in Hungary: Nationwide representative survey.
    Nagy A; Kovács N; Pálinkás A; Sipos V; Vincze F; Szőllősi G; Csenteri O; Ádány R; Sándor J
    Prim Care Diabetes; 2018 Jun; 12(3):199-211. PubMed ID: 29326023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex and age differences in the achievement of control targets in patients with type 2 diabetes: results from a population-based study in a South European region.
    Cambra K; Galbete A; Forga L; Lecea O; Ariz MJ; Moreno-Iribas C; Aizpuru F; Ibañez B
    BMC Fam Pract; 2016 Oct; 17(1):144. PubMed ID: 27729015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions.
    Kotseva K; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Abreu A; Aguiar C; Conde AC; Davletov K; Dilic M; Dolzhenko M; Gaita D; Georgiev B; Gotcheva N; Lalic N; Laucevicius A; Lovic D; Mancas S; Miličić D; Oganov R; Pajak A; Pogosova N; Reiner Ž; Vulic D; Wood D; On Behalf Of The Euroaspire Investigators
    Eur J Prev Cardiol; 2016 Dec; 23(18):2007-2018. PubMed ID: 27638542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
    Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
    Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries.
    Kotseva K; De Backer G; De Bacquer D; Rydén L; Hoes A; Grobbee D; Maggioni A; Marques-Vidal P; Jennings C; Abreu A; Aguiar C; Badariene J; Bruthans J; Cifkova R; Davletov K; Dilic M; Dolzhenko M; Gaita D; Gotcheva N; Hasan-Ali H; Jankowski P; Lionis C; Mancas S; Milićić D; Mirrakhimov E; Oganov R; Pogosova N; Reiner Ž; Vulić D; Wood D;
    Eur J Prev Cardiol; 2021 May; 28(4):370-379. PubMed ID: 33966079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achievement of cardiovascular risk factor targets according to sex and previous history of cardiovascular disease in type 2 diabetes: A population-based study.
    Galbete A; Cambra K; Forga L; Baquedano FJ; Aizpuru F; Lecea O; Librero J; Ibáñez B
    J Diabetes Complications; 2019 Dec; 33(12):107445. PubMed ID: 31668588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in the effect of HbA1c-defined diabetes on a wide range of cardiovascular disease risk factors.
    Du T; Yuan G; Zhou X; Sun X
    Ann Med; 2016; 48(1-2):34-41. PubMed ID: 26758477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment target achievement after myocardial infarction and ischaemic stroke: cardiovascular risk factors, medication use, and lifestyle: the Tromsø Study 2015-16.
    Hopstock LA; Morseth B; Cook S; Eggen AE; Grimsgaard S; Lundblad MW; Løchen ML; Mathiesen E; Nilsen A; Njølstad I
    Eur J Prev Cardiol; 2022 Mar; 29(2):362-370. PubMed ID: 33778888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.
    Comaschi M; Coscelli C; Cucinotta D; Malini P; Manzato E; Nicolucci A;
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):204-11. PubMed ID: 15955469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: data from the Adult Diabetes Control and Management.
    Sazlina SG; Mastura I; Ahmad Z; Cheong AT; Adam BM; Jamaiyah H; Lee PY; Syed-Alwi SA; Chew BH; Sriwahyu T
    Geriatr Gerontol Int; 2014 Jan; 14(1):130-7. PubMed ID: 23581598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel determinants preventing achievement of major cardiovascular targets in type 2 diabetes.
    Camara S; Bouenizabila E; Hermans MP; Ahn SA; Rousseau MF
    Diabetes Metab Syndr; 2014; 8(3):145-51. PubMed ID: 25220917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cardiovascular risk factors among Hungarian university students in Budapest.
    Antal M; Nagy K; Regoly-Mérei A; Bíró L; Szabó C; Rabin B
    Ann Nutr Metab; 2006; 50(2):103-7. PubMed ID: 16373992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.